ertugliflozin 5 MG Oral Tablet

RxCUI
1992810
RxNorm name
ertugliflozin 5 MG Oral Tablet
Display name
ertugliflozin 5 MG Oral Tablet
Full name
ertugliflozin 5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
STEGLATROERTUGLIFLOZINMerck Sharp & Dohme LLCe6f3e718-bb99-48f1-ab94-b9f0af05fed62026-06-03Warnings, Adverse reactionsExact identifier
rxcui: 1992810

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e6f3e718-bb99-48f1-ab94-b9f0af05fed6ertugliflozin 5 MG Oral Tablet [PSN] · ertugliflozin 5 MG Oral Tablet [SCD]216These highlights do not include all the information needed to use STEGLATRO safely and effectively. See full prescribing information for STEGLATRO. STEGLATRO ® (ertugliflozin) tablets, for oral use Initial U.S. Approval: 201720241220